<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<title>article159</title>
<style>
        body {
            font-family: Arial, sans-serif;
            margin: 0;
            padding: 0;
            background-color: #f3f3f3;
        }
        .container {
            max-width: 800px;
            margin: auto;
            background: #fff;
            padding: 20px;
            box-shadow: 0 0 10px rgba(0, 0, 0, 0.1);
        }
        h1, h2 {
            color: #333;
        }
        p {
            line-height: 1.6;
        }
        a {
            text-decoration: none;
            color: #5a5a5a;
        }
        a:hover {
            color: #000;
        }
    </style>
</head>
<body>
<div class="container"><p><a href="../index.html">Back to Index</a></p><li><a href="https://www.wikijournalclub.org/wiki/DANISH" style="display:block; margin-bottom:10px;">DANISH Original</a></li>
<h2><strong>DANISH</strong></h2>
<div class="container">
<h2><strong></strong></h2>
<div class="container">
<div class="container">
<h2><strong></strong></h2>
<h2><strong></strong></h2>

    "ICD in Patients with Nonischemic Systolic Heart Failure and the Risk of Sudden Cardiac Death". The New England Journal of Medicine. 2016. DOI: 10.1056/NEJMoa1608029.<br/>
<br/>
<h2><strong>Clinical Question</strong></h2><br/>
Does prophylactic ICD implantation reduce the long-term mortality in patients with symptomatic systolic heart failure not caused by coronary artery disease compared to usual clinical care?<br/>
<br/>
<h2><strong>Bottom Line</strong></h2><br/>
Prophylactic ICD implantation in patients with symptomatic systolic heart failure not caused by coronary artery disease did not significantly lower the long-term rate of death from any cause when compared to usual clinical care, although it halved the risk of sudden cardiac death.<br/>
<br/>
<h2><strong>Major Points</strong></h2><br/><br/>
<br/>
<h2><strong>Guidelines</strong></h2><br/>
At the time of the study, guidelines suggested class 1 recommendations for ICD implantation in patients with symptomatic systolic heart failure, with stronger evidence for ischemic versus nonischemic causes.<br/>
<br/>
<h2><strong>Design</strong></h2><br/>
- Multicenter, randomized, controlled trial<br/>
- N = 1,116 patients with symptomatic systolic heart failure not due to coronary artery disease<br/>
- Randomized to ICD (n = 556) vs usual clinical care (n = 560)<br/>
- Median follow-up: 67.6 months<br/>
- Trial conducted in Denmark<br/>
<br/>
<h2><strong>Population</strong></h2><br/>
- Inclusion criteria: Patients with symptomatic systolic heart failure (LVEF ≤ 35%), not due to coronary artery disease, and NT-proBNP &gt; 200 pg/mL<br/>
- Exclusion criteria: Permanent atrial fibrillation with resting heart rate &gt; 100 bpm, renal failure requiring dialysis<br/>
<br/>
<h2><strong>Interventions</strong></h2><br/>
- ICD group (n = 556)<br/>
- Usual clinical care (control) group (n = 560)<br/>
- 58% of patients received CRT in both groups<br/>
<br/>
<h2><strong>Outcomes</strong></h2><br/>
- The primary outcome was death from any cause.<br/>
- Secondary outcomes were sudden cardiac death and cardiovascular death.<br/>
- Sudden cardiac death occurred less frequently in the ICD group (4.3% vs 8.2%, HR 0.50; P=0.005).<br/>
- No significant difference in all-cause mortality (HR 0.87; P=0.28)<br/>
- Device infection occurred in 4.9% of ICD group and 3.6% of control group (P=0.29).<br/>
<br/>
<h2><strong>Criticisms</strong></h2><br/>
- Unblinded design.<br/>
<br/>
<h2><strong>Funding</strong></h2><br/>
- Funded by Medtronic, St. Jude Medical, TrygFonden, and the Danish Heart Foundation.<br/>
<br/>
<h2><strong>Further Reading</strong></h2><br/>
- Køber L, Thune JJ, Nielsen JC., et al. "Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure." NEJM. 2016;375(13):1221-1230. DOI: 10.1056/NEJMoa1608029.
    <p></p>
</div>
</div>
</div>
</div>
</body>
</html>
